This represents a significant advance over systemic or subcutaneous peptide delivery
Jing Y, Yu Y, Bai F, Wang L, Yang D, Zhang C, et al
Instead of a quick zap, you get a gradual, steady supply that keeps giving your body those antioxidant perks over time
The hAMY 3 R cells were cultured in growth medium consisting of DMEM (Gibco, #31966-021) supplemented with 10% v/v FBS (Gibco, #16140-071), 1% v/v Penicillin-Streptomycin (Gibco, #15140-122), 0.5 mg/mL Geneticin G418 (Gibco, #10131-027), 0.4 mg/mL Hygromycin (Invitrogen, #10687010) and 250 nM Methotrexate (Sigma, A6770)
Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation